Minimally-Invasive Reshaping of Heart Geometry for Mitral Regurgitation - European Reimbursement Report

  • ID: 4243322
  • Report
  • Region: Europe
  • European Med Tech Reimbursement Consulting AB
1 of 3
Essential Information About Reimbursement and National Funding of the Minimally-Invasive Reshaping of Heart Geometry for Mitral Regurgitation

Report presents summary of the reimbursement situation for a specific minimally invasive procedure of reshaping of heart geometry for mitral regurgitation. The technology is intended to shape base of the heart and improve coaptation of the leaflets when mitral regurgitation is caused by annular dilation and valve itself remains intact, without structural defects of degeneration.

Report includes essential information about reimbursement and national funding of the minimally-invasive reshaping of heart geometry for mitral regurgitation, including:

  • Brief overview of reimbursement system for medical devices
  • Procedure coding for technology
  • Diagnosis coding
  • Payment mechanism for technology
  • Reimbursement tariffs for technology
  • Restrictions in indications or scenarios for use of technology
  • Policy considerations by payers and policy-makers about technology

Reimbursement information is provided for the following geographies:

  • Austria
  • Belgium
  • Denmark
  • England (UK)
  • France
  • Germany
  • Italy
  • Netherlands
  • Norway
  • Sweden
  • Switzerland
Note: Product cover images may vary from those shown
2 of 3

1. Introduction and summary

2. Executive summary table

3. Contents

4. Methodology

5. Reimbursement analysis in Austria
5.1. Overview of the reimbursement system
5.2. Reimbursement for minimally invasive reshaping of heart geometry

6. Reimbursement analysis in Belgium
6.1. Overview of the reimbursement system
6.2. Reimbursement for minimally invasive reshaping of heart geometry

7. Reimbursement analysis in Denmark
7.1. Overview of the reimbursement system
7.2. Reimbursement for minimally invasive reshaping of heart geometry

8. Reimbursement analysis in England
8.1. Overview of the reimbursement system
8.2. Reimbursement for minimally invasive reshaping of heart geometry
8.2.1. Procedure coding
8.2.2. Diagnosis coding
8.2.3. Payment mechanism and reimbursement tariffs
8.2.4. Policy considerations
8.2.4.1. National commissioning by NHS England

9. Reimbursement analysis in France
9.1. Overview of the reimbursement system
9.2. Reimbursement for minimally invasive reshaping of heart geometry

10. Reimbursement analysis in Germany
10.1. Overview of the reimbursement system
10.2. Reimbursement for minimally invasive reshaping of heart geometry
10.2.1. Procedure coding
10.2.2. Diagnosis coding
10.2.3. Payment mechanism and reimbursement tariffs
10.2.4. Policy considerations

11. Reimbursement analysis in Italy
11.1. Overview of the reimbursement system
11.2. Reimbursement for minimally invasive reshaping of heart geometry
11.2.1. Procedure coding at national level
11.2.2. Diagnosis coding
11.2.3. Payment mechanism and reimbursement tariffs at national level
11.2.4. Payment mechanism and reimbursement tariffs at regional level

12. Reimbursement analysis in the Netherlands
12.1. Overview of the reimbursement system
12.2. Reimbursement for minimally invasive reshaping of heart geometry

13. Reimbursement analysis in Norway
13.1. Overview of the reimbursement system
13.2. Reimbursement for minimally invasive reshaping of heart geometry

14. Reimbursement analysis in Sweden
14.1. Overview of the reimbursement system
14.2. Reimbursement for minimally invasive reshaping of heart geometry

15. Reimbursement analysis in Switzerland
15.1. Overview of the reimbursement system
15.2. Reimbursement for minimally invasive reshaping of heart geometry
15.2.1. Procedure coding
15.2.2. Diagnosis coding
15.2.3. Payment mechanism and reimbursement tariffs
15.2.4. Policy considerations

16. Disclaimer

Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll